Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models.

Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models.
复制标题

DOI:
10.18632/oncotarget.24264
复制
发表时间:
2018-02-16
期刊:
影响因子:
--
通讯作者:
Hoffman RM
Hoffman RM
中科院分区:
其他
文献类型:
--
作者:
Kawaguchi K;Han Q;Li S;Tan Y;Igarashi K;Miyake K;Kiyuna T;Miyake M;Chemielwski B;Nelson SD;Russell TA;Dry SM;Li Y;Singh AS;Eckardt MA;Unno M;Eilber FC;Hoffman RM

文献摘要

被引文献

相似文献

生长对甲硫氨酸(MET)的过度需求,称为MET依赖性,似乎是癌症中的一般代谢缺陷。我们以前已经表明,癌细胞的生长可以选择性地阻止MET限制,如重组蛋氨酸酶(rMET酶)。在本研究中,我们利用患者来源的胰腺癌或黑色素瘤原位异种移植(PDOX)裸鼠模型来确定肿瘤内MET水平与肿瘤大小之间的关系。在肿瘤生长至100 mm3后,将PDOX裸鼠分成两组:未处理的对照组和用rMET酶(100单位,i.p.,连续14天)。在治疗开始后第14天,测量肿瘤内MET水平,发现其与肿瘤体积高度相关,在胰腺癌PDOX(p<0.0001,R2=0.89016)和黑素瘤PDOX(p<0.0001,R2=0.88114)中均如此。低浓度MET组肿瘤较小。目前的结果表明,患者肿瘤的生长高度依赖于MET,并且rMET酶有效地降低了肿瘤MET。
An excessive requirement for methionine (MET) for growth, termed MET dependence, appears to be a general metabolic defect in cancer. We have previously shown that cancer-cell growth can be selectively arrested by MET restriction such as with recombinant methioninase (rMETase). In the present study, we utilized patient-derived orthotopic xenograft (PDOX) nude mouse models with pancreatic cancer or melanoma to determine the relationship between intra-tumor MET level and tumor size. After the tumors grew to 100 mm3, the PDOX nude mice were divided into two groups: untreated control and treated with rMETase (100 units, i.p., 14 consecutive days). On day 14 from initiation of treatment, intra-tumor MET levels were measured and found to highly correlate with tumor volume, both in the pancreatic cancer PDOX (p<0.0001, R2=0.89016) and melanoma PDOX (p<0.0001, R2=0.88114). Tumors with low concentration of MET were smaller. The present results demonstrates that patient tumors are highly dependent on MET for growth and that rMETase effectively lowers tumor MET.